Prognostic	B:C1514474
significance	I:C1514474
of	O
non-HPV16	O
genotypes	O
in	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
.	O

Prognostic	O
significance	I:C1514474
of	O
non-HPV16	O
genotypes	O
in	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
.	O

Recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
)	O
positive	O
for	O
HPV16	O
genotype	I:C3872681
have	O
better	O
overall	O
survival	O
compared	O
with	O
cases	O
positive	O
for	O
other	O
HPV	O
genotypes	O
.	O

Recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
)	O
positive	O
for	O
HPV16	O
genotype	I:C3872681
have	O
better	O
overall	O
survival	O
compared	O
with	O
cases	O
positive	O
for	O
other	O
HPV	O
genotypes	O
.	O

Recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
)	O
positive	B:C4288937
for	O
HPV16	O
genotype	I:C3872681
have	O
better	O
overall	O
survival	O
compared	O
with	O
cases	O
positive	O
for	O
other	O
HPV	O
genotypes	O
.	O

Recent	O
studies	O
have	O
found	O
that	O
cases	O
with	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
)	O
positive	O
for	O
HPV16	B:C3872681
genotype	I:C3872681
have	O
better	O
overall	O
survival	O
compared	O
with	O
cases	O
positive	O
for	O
other	O
HPV	O
genotypes	O
.	O

We	O
sought	O
to	O
further	O
replicate	O
these	O
studies	O
and	O
determine	O
if	O
this	O
relationship	O
is	O
modified	O
by	O
expression	B:C1171362
of	O
p16	O
tumor	I:C0249880
suppressor	I:C0249880
protein	I:C0249880
.	O

We	O
sought	O
to	O
further	O
replicate	O
these	O
studies	O
and	O
determine	O
if	O
this	O
relationship	O
is	O
modified	O
by	O
expression	O
of	O
p16	B:C0249880
tumor	I:C0249880
suppressor	I:C0249880
protein	I:C0249880
.	O

We	O
identified	O
238	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
from	O
the	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
(	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
)	O
study	O
,	O
a	O
population	O
based	I:C1709599
case	I:C1709599
-	I:C1709599
control	I:C1709599
study	I:C1709599
.	O

We	O
identified	O
238	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
from	O
the	O
Carolina	B:C1516225
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
(	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
)	O
study	O
,	O
a	O
population	O
based	I:C1709599
case	I:C1709599
-	I:C1709599
control	I:C1709599
study	I:C1709599
.	O

We	O
identified	O
238	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
from	O
the	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
(	O
Carolina	B:C1516225
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
)	O
study	O
,	O
a	O
population	O
based	I:C1709599
case	I:C1709599
-	I:C1709599
control	I:C1709599
study	I:C1709599
.	O

We	O
identified	O
238	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
from	O
the	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
(	O
Carolina	O
Head	I:C1516225
and	I:C1516225
Neck	I:C1516225
Cancer	I:C1516225
Study	I:C1516225
)	O
study	O
,	O
a	O
population	B:C1709599
based	I:C1709599
case	I:C1709599
-	I:C1709599
control	I:C1709599
study	I:C1709599
.	O

Tumors	B:C0027651
that	O
tested	O
positive	O
solely	I:C4288937
for	O
HPV16	O
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	O
were	O
classified	O
as	O
HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
that	O
tested	O
positive	B:C4288937
solely	I:C4288937
for	O
HPV16	O
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	O
were	O
classified	O
as	O
HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
that	O
tested	O
positive	O
solely	I:C4288937
for	O
HPV16	B:C3872681
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	O
were	O
classified	O
as	O
HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
that	O
tested	O
positive	O
solely	I:C4288937
for	O
HPV16	O
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	B:C0032520
were	O
classified	O
as	O
HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
that	O
tested	O
positive	O
solely	I:C4288937
for	O
HPV16	O
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	O
were	O
classified	B:C0008902
as	O
HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
that	O
tested	O
positive	O
solely	I:C4288937
for	O
HPV16	O
genotype	I:C3872681
and	O
no	O
other	O
genotypes	O
with	O
PCR	O
were	O
classified	O
as	O
HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
.	O

Tumors	B:C0027651
positive	O
for	I:C4288937
any	O
other	O
high	O
-	I:C0332167
risk	I:C0332167
HPV	O
genotype	I:C3872595
were	O
classified	O
as	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
positive	B:C4288937
for	I:C4288937
any	O
other	O
high	O
-	I:C0332167
risk	I:C0332167
HPV	O
genotype	I:C3872595
were	O
classified	O
as	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
positive	O
for	I:C4288937
any	O
other	O
high	B:C0332167
-	I:C0332167
risk	I:C0332167
HPV	O
genotype	I:C3872595
were	O
classified	O
as	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
positive	O
for	I:C4288937
any	O
other	O
high	O
-	I:C0332167
risk	I:C0332167
HPV	B:C3872595
genotype	I:C3872595
were	O
classified	O
as	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
positive	O
for	I:C4288937
any	O
other	O
high	O
-	I:C0332167
risk	I:C0332167
HPV	O
genotype	I:C3872595
were	O
classified	B:C0008902
as	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
.	O

Tumors	O
positive	O
for	I:C4288937
any	O
other	O
high	O
-	I:C0332167
risk	I:C0332167
HPV	O
genotype	I:C3872595
were	O
classified	O
as	O
non-HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
.	O

Expression	B:C1171362
of	O
p16	O
in	O
the	O
tumor	O
was	O
determined	O
with	O
immunohistochemistry	O
.	O

Expression	O
of	O
p16	B:C0249880
in	O
the	O
tumor	O
was	O
determined	O
with	O
immunohistochemistry	O
.	O

Expression	O
of	O
p16	O
in	O
the	O
tumor	B:C0027651
was	O
determined	O
with	O
immunohistochemistry	O
.	O

Expression	O
of	O
p16	O
in	O
the	O
tumor	O
was	O
determined	O
with	O
immunohistochemistry	B:C0021044
.	O

Hazard	O
ratios	O
(	O
HR	O
)	O
adjusted	O
for	O
smoking	O
,	O
alcohol	O
use	O
,	O
sex	O
,	O
race	B:C0034510
,	O
and	O
age	O
was	O
calculated	O
with	O
the	O
Cox	O
proportional	I:C0010235
hazard	I:C0010235
regression	I:C0010235
.	O

Hazard	O
ratios	O
(	O
HR	O
)	O
adjusted	O
for	O
smoking	O
,	O
alcohol	O
use	O
,	O
sex	O
,	O
race	O
,	O
and	O
age	O
was	O
calculated	O
with	O
the	O
Cox	B:C0010235
proportional	I:C0010235
hazard	I:C0010235
regression	I:C0010235
.	O

Cases	O
with	O
HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
better	O
overall	O
survival	O
than	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
log-	O
rank	O
p-value	O
:	O
0.010	O
)	O
.	O

Cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
better	O
overall	O
survival	O
than	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
log-	O
rank	O
p-value	O
:	O
0.010	O
)	O
.	O

Cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
better	O
overall	O
survival	O
than	O
cases	O
with	O
non-HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
log-	O
rank	O
p-value	O
:	O
0.010	O
)	O
.	O

Cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
better	O
overall	O
survival	O
than	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
(	O
log-	O
rank	O
p-value	O
:	O
0.010	O
)	O
.	O

When	O
restricted	O
to	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
positive	O
for	O
p16	O
expression	I:C1171362
,	O
the	O
same	O
trend	O
continued	O
(	O
log-	O
rank	O
p-value	O
:	O
0.002	O
)	O
.	O

When	O
restricted	O
to	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
positive	B:C1446409
for	O
p16	O
expression	I:C1171362
,	O
the	O
same	O
trend	O
continued	O
(	O
log-	O
rank	O
p-value	O
:	O
0.002	O
)	O
.	O

When	O
restricted	O
to	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
cases	O
positive	O
for	O
p16	B:C1171362
expression	I:C1171362
,	O
the	O
same	O
trend	O
continued	O
(	O
log-	O
rank	O
p-value	O
:	O
0.002	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	O
risk	I:C0332167
of	I:C0332167
death	O
compared	O
to	O
cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
tumors	O
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	O
risk	I:C0332167
of	I:C0332167
death	O
compared	O
to	O
cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
tumors	O
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	B:C0332167
risk	I:C0332167
of	I:C0332167
death	O
compared	O
to	O
cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
tumors	O
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	O
risk	I:C0332167
of	I:C0332167
death	B:C1306577
compared	O
to	O
cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
tumors	O
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	O
risk	I:C0332167
of	I:C0332167
death	O
compared	O
to	O
cases	O
with	O
HPV16	B:C4288937
-	I:C4288937
positive	I:C4288937
tumors	O
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

In	O
the	O
adjusted	O
model	O
,	O
cases	O
with	O
non-HPV16	O
-	I:C4288937
positive	I:C4288937
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
had	O
greater	O
risk	I:C0332167
of	I:C0332167
death	O
compared	O
to	O
cases	O
with	O
HPV16	O
-	I:C4288937
positive	I:C4288937
tumors	B:C0027651
(	O
HR	O
:	O
1.92	O
;	O
95	O
%	O
CI	O
:	O
1.03	O
,	O
3.60	O
)	O
.	O

This	O
finding	B:C0243095
indicates	O
that	O
HPV	O
genotyping	O
carries	O
valuable	O
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	O
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

This	O
finding	O
indicates	B:C1444656
that	O
HPV	O
genotyping	O
carries	O
valuable	O
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	O
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

This	O
finding	O
indicates	O
that	O
HPV	B:C0021344
genotyping	O
carries	O
valuable	O
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	O
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

This	O
finding	O
indicates	O
that	O
HPV	O
genotyping	O
carries	O
valuable	B:C1514474
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	O
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

This	O
finding	O
indicates	O
that	O
HPV	O
genotyping	O
carries	O
valuable	O
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	B:C0249880
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	O
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

This	O
finding	O
indicates	O
that	O
HPV	O
genotyping	O
carries	O
valuable	O
prognostic	I:C1514474
significance	I:C1514474
in	O
addition	O
to	O
p16	O
status	O
and	O
future	O
survival	O
studies	O
of	O
oropharyngeal	B:C0280313
squamous	I:C0280313
cell	I:C0280313
carcinoma	I:C0280313
should	O
take	O
into	O
account	O
differing	O
HPV	O
genotypes	O
.	O

